Free access for registered Healthcare Professionals and home of "The Oncology Podcast"
Join us today for the latest oncology news, commentary, educational resources and podcasts
oncologynetwork.com.au
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Prof Mark Shackleton joins us to discuss how the MPCCC is transforming cancer care access across Victoria—through molecular tumour boards, fellowships & more.
Don't miss it.
🎙️http://t.ly/dks3m
#Oncology #MPCCC #HealthcareEquity #CanSky #OncSky #MedSky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social
Join Tim Price & Jeanne Tie for From Consensus to Clinic: Part 2 as they dive into managing BRAFV600E-mutant mCRC
🔬 Imaging & monitoring
🧬 ctDNA & tumour markers
🎯 Local ablative therapies & more!
Listen: t.ly/U7DZs
#GICancer #mCRC #OncSky #OncoSky #MedSky #GISky #CanSky
𝗗𝗘𝗜 in healthcare has been 𝘀𝗵𝗮𝗸𝗲𝗻 𝘁𝗼 𝗶𝘁𝘀 𝗰𝗼𝗿𝗲. 𝗣𝗿𝗼𝗳 𝗖𝗿𝗮𝗶𝗴 𝗨𝗻𝗱𝗲𝗿𝗵𝗶𝗹𝗹, 𝗗𝗿. 𝗞𝗮𝘁𝗲 𝗖𝗹𝗮𝗿𝗸e & 𝗣𝗿𝗼𝗳 𝗖𝗵𝗿𝗶𝘀 𝗝𝗮𝗰𝗸𝘀𝗼𝗻 discuss these radical shifts & what they mean for the future of equitable cancer care.
👉 𝗟𝗶𝘀𝘁𝗲𝗻 𝗻𝗼𝘄 tinyurl.com/4b8hbpc6
@craigunderhill.bsky.social #MedSky
𝗗𝗘𝗜 in healthcare has been 𝘀𝗵𝗮𝗸𝗲𝗻 𝘁𝗼 𝗶𝘁𝘀 𝗰𝗼𝗿𝗲. 𝗣𝗿𝗼𝗳 𝗖𝗿𝗮𝗶𝗴 𝗨𝗻𝗱𝗲𝗿𝗵𝗶𝗹𝗹, 𝗗𝗿. 𝗞𝗮𝘁𝗲 𝗖𝗹𝗮𝗿𝗸e & 𝗣𝗿𝗼𝗳 𝗖𝗵𝗿𝗶𝘀 𝗝𝗮𝗰𝗸𝘀𝗼𝗻 discuss these radical shifts & what they mean for the future of equitable cancer care.
👉 𝗟𝗶𝘀𝘁𝗲𝗻 𝗻𝗼𝘄 tinyurl.com/4b8hbpc6
@craigunderhill.bsky.social #MedSky
Join Profs @Tim Price & @JeanneTie to break down the latest expert consensus on #BRAFV600E-mutant #mCRC in the Asia-Pacific region
🎙️ PART 1: Molecular testing, treatment sequencing & BEACON insights—don’t miss it!
🔗 t.ly/idW9V #medsky #oncsky #cansky #GIsky #cancer
Join Profs @Tim Price & @JeanneTie to break down the latest expert consensus on #BRAFV600E-mutant #mCRC in the Asia-Pacific region
🎙️ PART 1: Molecular testing, treatment sequencing & BEACON insights—don’t miss it!
🔗 t.ly/idW9V #medsky #oncsky #cansky #GIsky #cancer
Dive into the evolving world of HER2-low expression in metastatic breast cancer.
🎙️ Join Prof. Fran Boyle & Dr. Sanjeev Kumar to unpack HER2 testing, patient comms & emerging therapies
🔗 Listen now: t.ly/jFmny #MedSky #OncSky #CanSky #OncologyPodcast #BreastCancer #HER2Low #HER2
Dive into the evolving world of HER2-low expression in metastatic breast cancer.
🎙️ Join Prof. Fran Boyle & Dr. Sanjeev Kumar to unpack HER2 testing, patient comms & emerging therapies
🔗 Listen now: t.ly/jFmny #MedSky #OncSky #CanSky #OncologyPodcast #BreastCancer #HER2Low #HER2
Hosted by @bogda-koczwara.bsky.social with Prof Sophie Lebel + A/Prof Ben Smith
🔗 Listen now: t.ly/L5qvM
#CancerSurvivorship #FearOfCancerRecurrence #FCR #OncologyCare #CanSky #OncSky #MedSky
Hosted by @bogda-koczwara.bsky.social with Prof Sophie Lebel + A/Prof Ben Smith
🔗 Listen now: t.ly/L5qvM
#CancerSurvivorship #FearOfCancerRecurrence #FCR #OncologyCare #CanSky #OncSky #MedSky